GlassScriptPhysician profile
Eze Okeagu
NPI 1639550544
$38,762.98
in general payments reported to CMS, 2019-2025
11 companies · $779 in 2025
The $779 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $974 · 2022: $2,926 · 2023: $32K · 2024: $2,271 · 2025: $779.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $28K · Travel and Lodging: $3,496 · Food and Beverage: $3,087 · Education: $142.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $28,136.50 |
| Travel and Lodging | $3,496.40 |
| Food and Beverage | $3,087.29 |
| Education | $142.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $16,686.81 | 2022-2025 | Micra, Linq II, Flexcath Advance |
| Abbott Laboratories | $15,591.88 | 2022-2025 | Amplatzer Amulet, Ensite, Aveir |
| Biotronik INC. | $3,656.78 | 2020-2024 | Pamira, Solia, Acticor 7 Vr-T Dx |
| Boston Scientific Corporation | $1,767.00 | 2023-2025 | Watchman Flx, Farapulse, General - Therapies |
| Biosense Webster, INC. | $653.77 | 2022-2025 | Carto 3, Qdot Micro Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $202.60 | 2022-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $87.38 | 2024-2025 | |
| Cardiva Medical, INC. | $39.53 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Angiodynamics, INC. | $28.96 | 2025 | Auryon Laser System 100-120 Vac |
| Abiomed | $25.57 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $22.70 | 2024 | Camzyos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eze Okeagu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.